CACaption Management, LLC
Institutional investor · Portfolio as of Q1 2019
Top Holdings540 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
CELGENE CORP | 531,600 | $50.2M | 2.8% | — | — | — | New — |
BRISTOL-MYERS SQUIBB CO | 997,200 | $47.6M | 2.6% | — | — | — | New — |
WALT DISNEY CO/THE | 290,400 | $32.2M | 1.8% | — | — | — | New — |
BOEING CO/THE | 76,600 | $29.2M | 1.6% | — | — | — | New — |
TAPESTRY INC | 864,000 | $28.1M | 1.5% | — | — | — | New — |
BRISTOL-MYERS SQUIBB CO | 498,500 | $23.8M | 1.3% | — | — | — | New — |
TARGA RESOURCES CORP | 552,100 | $22.9M | 1.3% | — | — | — | New — |
NOVAVAX INC | 2M | $22.3M | 1.2% | — | — | — | — |
WAGEWORKS INC | 550,500 | $20.8M | 1.1% | — | — | — | New — |
BOEING CO/THE | 50,000 | $19.1M | 1.1% | — | — | — | New — |
TAPESTRY INC | 580,000 | $18.8M | 1.0% | $27.18 | 0.00% | 1 qtr | New 65 |
ASCENDIS PHARMA A/S | 153,800 | $18.1M | 1.0% | — | — | — | New — |
UNION PACIFIC CORP | 100,000 | $16.7M | 0.9% | — | — | — | New — |
ZIMMER HOLDINGS INC | 130,000 | $16.6M | 0.9% | — | — | — | New — |
PAPA JOHNS INTL INC | 293,200 | $15.5M | 0.9% | — | — | — | New — |
CENTENE CORP | 270,000 | $14.3M | 0.8% | — | — | — | New — |
CELGENE CORP | 149,100 | $14.1M | 0.8% | — | — | — | New — |
MEDICINES CO | 494,900 | $13.8M | 0.8% | — | — | — | New — |
EXACT SCIENCES CORP | 158,800 | $13.8M | 0.8% | — | — | — | New — |
P G & E CORP | 758,500 | $13.5M | 0.7% | — | — | — | New — |
Caption Management, LLC manages $1.8B across 540 positions as of Q1 2019. Top holdings: CELG (2.8%), BMY (2.6%), DIS (1.8%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 189 new positions, 0 exits, 0 increased. Top move: TPR (NEW, conviction 65). Portfolio: $1.8B across 540 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer